Welcome Guest!  Login | Register | Help
Home News Screener Maps Groups Portfolio Insider Futures Forex Collaborate Store Elite
CRME [NASD]
Cardiome Pharma Corp.
Index- P/E3.59 EPS (ttm)0.54 Insider Own9.79% Shs Outstand12.47M Perf Week-9.77%
Market Cap24.19M Forward P/E- EPS next Y-0.07 Insider Trans- Shs Float11.89M Perf Month-11.82%
Income7.05M PEG0.13 EPS next Q1.48 Inst Own76.58% Short Float0.38% Perf Quarter-0.51%
Sales0.42M P/S57.60 EPS this Y34.56% Inst Trans-0.62% Short Ratio0.58 Perf Half Y38.57%
Book/sh2.11 P/B0.92 EPS next Y-16.70% ROA14.13% Target Price3.63 Perf Year-7.62%
Cash/sh2.06 P/C0.94 EPS next 5Y28.00% ROE31.47% 52W Range1.20 - 2.70 Perf YTD-0.51%
Dividend- P/FCF- EPS past 5Y0.00% ROI14.81% 52W High-28.15% Beta1.29
Dividend %- Quick Ratio- Sales past 5Y-29.62% Gross Margin- 52W Low61.67% ATR0.16
Employees13 Current Ratio13.20 Sales Q/Q-86.14% Oper. Margin2307.69% RSI (14)43.01 Volatility4.27% 7.47%
OptionableYes Debt/Eq0.00 EPS Q/Q358.22% Profit Margin1694.23% Rel Volume0.35 Prev Close1.94
ShortableYes LT Debt/Eq0.00 EarningsMar 07 Payout0.00% Avg Volume77.74K Price1.94
Recom3.20 SMA20-8.06% SMA50-1.50% SMA2005.53% Volume27,120 Change0.00%
20-Mar-12Downgrade RBC Capital Mkts Outperform → Sector Perform $6 → $1.50
27-Apr-11Upgrade RBC Capital Mkts Sector Perform → Outperform $8
08-Dec-10Initiated Wedbush Outperform $8.50
22-Oct-10Reiterated RBC Capital Mkts Sector Perform $10 → $9
23-Jun-10Reiterated UBS Buy $8.80 → $10.75
12-Aug-09Reiterated RBC Capital Mkts Sector Perform $11.50 → $9
19-Mar-09Reiterated Leerink Swann Outperform $8 → $6
01-Dec-08Reiterated Oppenheimer Outperform $18 → $15
17-Nov-08Reiterated Leerink Swann Outperform $15 → $8
12-Aug-08Reiterated RBC Capital Mkts Sector Perform $13.50 → $11.50
12-Aug-08Reiterated Lehman Brothers Equal-Weight $10 → $8
16-Jul-08Downgrade RBC Capital Mkts Outperform → Sector Perform $13.50
20-Mar-08Initiated Wachovia Outperform
11-Mar-08Initiated BMO Capital Markets Market Perform
09-Oct-07Initiated Lehman Brothers Equal-weight
23-Feb-07Initiated Bear Stearns Outperform $17
13-May-13 06:20PM  Cardiome Pharma Management Discusses Q1 2013 Results - Earnings Call Transcript at Seeking Alpha
09:00AM  Cardiome Reports First Quarter Results PR Newswire
09:00AM  Cardiome Reports First Quarter Results CNW Group
10-May-13 07:00AM  Cardiome To Present At Bloom Burton & Co. Healthcare Investor Conference PR Newswire
07:00AM  Cardiome To Present At Bloom Burton & Co. Healthcare Investor Conference CNW Group
09-May-13 01:00PM  Cardiome to Hold First Quarter 2013 Financial Results Conference Call on May 13 CNW Group
02-May-13 12:00PM  Cardiome Accepts the Transfer of Sponsorship of U.S. and Canadian Vernakalant IV and Oral Regulatory Filings from Merck CNW Group
25-Apr-13 01:45PM  Cardiome Announces Worldwide Sales And Marketing Of BRINAVESS CNW Group
17-Apr-13 01:04PM  CARDIOME PHARMA CORP Financials EDGAR Online Financials
12-Apr-13 08:00AM  Cardiome Announces Share Consolidation Effective April 12, 2013 CNW Group +5.95%
04-Apr-13 10:45AM  Cardiome Announces Shareholder Approval of Share Consolidation CNW Group
02-Apr-13 11:45AM  Cardiome Appoints Jürgen Polifka, Ph.D., as General Manager, Sales and Marketing Europe CNW Group +5.56%
28-Mar-13 07:15AM  Cardiome Announces The Addition Of Dr. Steen Juul-Möller As Medical Director, Europe PR Newswire
07:15AM  Cardiome Announces The Addition Of Dr. Steen Juul-Möller As Medical Director, Europe CNW Group
26-Mar-13 07:24PM  Cardiome Announces Changes to Senior Management Team PR Newswire
07:24PM  Cardiome Announces Changes to Senior Management Team CNW Group
23-Mar-13 01:04PM  CARDIOME PHARMA CORP Financials EDGAR Online Financials
19-Mar-13 04:17PM  InPlay: Cardiome Pharma reports that Independent Proxy Advisor Firms ISS and Glass Lewis recommend Cardiome shareholders vote in favor of share consolidation Briefing.com -5.41%
04:15PM  Independent Proxy Advisor Firms ISS and Glass Lewis Recommend Cardiome Shareholders Vote in Favor of Share Consolidation PR Newswire
04:15PM  Independent Proxy Advisor Firms ISS and Glass Lewis Recommend Cardiome Shareholders Vote in Favor of Share Consolidation CNW Group
18-Mar-13 07:19PM  New Star Analyst Rankings for Cardiome Pharma Corporation StarMine -5.13%
12:42PM  Cardiome Posts 4Q Profit Zacks
17-Mar-13 07:16PM  New Star Analyst Rankings for Cardiome Pharma Corporation StarMine
15-Mar-13 12:30PM  Cardiome Pharma Management Discusses Q4 2012 Results - Earnings Call Transcript at Seeking Alpha
07:15AM  Cardiome Reports Fourth Quarter and Full Year 2012 Financial Results PR Newswire
07:15AM  Cardiome Reports Fourth Quarter and Full Year 2012 Financial Results CNW Group
12-Mar-13 02:05PM  Cardiome to Hold Fourth Quarter and Full Year 2012 Financial Results Conference Call on March 15 PR Newswire
02:05PM  Cardiome to Hold Fourth Quarter and Full Year 2012 Financial Results Conference Call on March 15 CNW Group
04-Mar-13 08:54AM  InPlay: Cardiome announces settlement of debt and termination of line of credit with Merck (MRK) Briefing.com -6.82%
08:52AM  Cardiome announces settlement of debt and termination of line of credit with Merck PR Newswire
08:52AM  Cardiome announces settlement of debt and termination of line of credit with Merck CNW Group
12-Feb-13 04:28PM  Cardiome Selects Quintiles Zacks
04-Feb-13 04:19PM  InPlay: Cardiome Pharma selects Quintiles to manage global regulatory affairs and life cycle safety activities for BRINAVESS (vernakalant intravenous) Briefing.com
04:15PM  Cardiome Selects Quintiles To Manage Global Regulatory Affairs And Life Cycle Safety Activities For BRINAVESS (Vernakalant Intravenous) PR Newswire
04:15PM  Cardiome Selects Quintiles To Manage Global Regulatory Affairs And Life Cycle Safety Activities For BRINAVESS (Vernakalant Intravenous) CNW Group
31-Jan-13 10:48AM  4 Speculative Biotech Stocks To Consider at Seeking Alpha +9.09%
19-Dec-12 12:07PM  Cardiome Shares Remain Low On Merck's Abandonment at Seeking Alpha -11.36%
18-Dec-12 01:27PM  What No One Is Saying About Paramount Biosciences: 3 Case Histories And 4 Companies To Avoid at Seeking Alpha -12.00%
12-Dec-12 08:20AM  Higher Rate of FDA New Drug Approvals a Major Factor in Biotech Industry's Success in 2012 Marketwire +17.14%
11-Dec-12 10:36PM  Cardiome Repays Merck Debt, Isis Partners with AstraZeneca: Healthcare Business Recap at Wall St. Cheat Sheet +40.00%
02:49PM  Cardiome Repays Merck Debt, Isis Partners with AstraZeneca: Healthcare Business Recap at Wall St. Cheat Sheet
10:45AM  Cardiome to pay $20 million, settle debt deal with Merck at Reuters
08:45AM  InPlay from Briefing.com Briefing.com
08:13AM  InPlay from Briefing.com Briefing.com
08:09AM  InPlay: Cardiome Pharma reaches agreement with Merck (MRK) to retire debt and close line of credit Briefing.com
08:00AM  Cardiome Reaches Agreement With Merck to Retire Debt and Close Line of Credit GlobeNewswire
14-Nov-12 09:27AM  New Star Analyst Rankings for Cardiome Pharma Corporation StarMine
13-Nov-12 04:25PM  Cardiome Reports Third Quarter Results GlobeNewswire
31-Oct-12 05:02PM  InPlay: Cardiome Pharma: NASDAQ grants 180 day extension to regain compliance with bid price requirement Briefing.com
05:00PM  NASDAQ Grants Cardiome 180 Day Extension to Regain Compliance With Bid Price Requirement GlobeNewswire
25-Oct-12 04:15PM  NASDAQ Approves Cardiome's Request to Transfer Its Listing to The NASDAQ Capital Market GlobeNewswire
10-Oct-12 01:48PM  Merck Successes Create Buying Opportunity at Seeking Alpha
27-Sep-12 05:35AM  Healthcare Business Recap: Catalyst Pharma Suffers Delay, Medtronic Gets CE Mark at Wall St. Cheat Sheet -17.50%
26-Sep-12 11:03PM  Healthcare Business Update: Catalyst Pharma Suffers Delay, Medtronic Gets CE Mark at Wall St. Cheat Sheet +8.11%
03:26PM  Merck Returns To Cardiome All Rights To Atrial Fibrillation Drug Vernakalant at Forbes
12:53PM  Cardiome regains rights to Brinavess from Merck AP
08:09AM  InPlay: Cardiome Pharma: Merck (MRK) returns global marketing and development rights for vernakalant to Cardiome Briefing.com
08:05AM  Cardiome to Hold Conference Call GlobeNewswire
08:04AM  Merck Returns Global Marketing and Development Rights for Vernakalant to Cardiome GlobeNewswire
21-Sep-12 06:36PM  Healthcare Business Roundup: Astex Abandons Cancer Drug, LabCorp Sues VA at Wall St. Cheat Sheet +11.43%
20-Sep-12 04:37PM  Cardiome names Jennifer Archibald as CFO at theflyonthewall.com
04:30PM  InPlay: Cardiome announces appointment of Jennifer Archibald as Chief Financial Officer Briefing.com
04:30PM  Cardiome Announces Appointment of Jennifer Archibald as Chief Financial Officer GlobeNewswire
10-Sep-12 08:45AM  Cardiome Notes Updated Guidelines From European Society of Cardiology Now Include Brinavess(TM) (Vernakalant) for Infusion GlobeNewswire
21-Aug-12 04:45PM  Cardiome to Hold Investor Update Call GlobeNewswire
07-Aug-12 08:30PM  Cardiome Reports Second Quarter Results GlobeNewswire
09-Jul-12 09:21AM  InPlay: Cardiome Pharma is undertaking significant workforce reduction as response to termination of Merck's development efforts relating to the vernakalant oral program Briefing.com
09:15AM  Cardiome Announces Workforce Reduction GlobeNewswire
08:58AM  InPlay: Cardiome Pharma halted, news pending Briefing.com
03-Jul-12 03:48PM  Cardiome Pharma says CEO Janzen left the company AP
12:30PM  InPlay: Cardiome Pharma announced that CEO Doug Janzen has left the Company Briefing.com
12:29PM  Cardiome says CEO Doug Janzen has left company at theflyonthewall.com
12:28PM  Cardiome Announces Management Change PR Newswire
12:28PM  Cardiome Announces Management Change CNW Group
09:40AM  Diana Containerships: High-Yield Dividend Play With Mid-Term Charters at Seeking Alpha
14-May-12 09:41AM  New Star Analyst Rankings for Cardiome Pharma Corporation StarMine
13-May-12 09:38AM  New Star Analyst Rankings for Cardiome Pharma Corporation StarMine
11-May-12 04:00PM  Cardiome Reports First Quarter Results GlobeNewswire
10-May-12 05:06PM  Cardiome to Release First Quarter 2012 Financial Results GlobeNewswire +8.33%
04-May-12 06:01PM  Cardiome Receives Notification From NASDAQ GlobeNewswire
31-Mar-12 01:04PM  CARDIOME PHARMA CORP Financials EDGAR Online Financials
28-Mar-12 09:51AM  New Star Analyst Rankings for Cardiome Pharma Corporation StarMine -5.19%
27-Mar-12 05:09PM  Cardiome Pharma 4Q loss shrinks on lower costs AP
03:33PM  Cardiome Reports 2011 Results GlobeNewswire
02:29PM  Cardiome to Release Fourth Quarter and Fiscal 2011 Results GlobeNewswire
23-Mar-12 10:29AM  On The Fly: Analyst Downgrade Summary theflyonthewall.com
22-Mar-12 10:19AM  On The Fly: Analyst Downgrade Summary theflyonthewall.com
21-Mar-12 06:06PM  Nasdaq stocks posting largest volume increases AP
20-Mar-12 06:09PM  Nasdaq stocks posting largest volume increases AP
02:15PM  Merck Drops Oral Vernakalant Zacks
10:31AM  On The Fly: Analyst Downgrade Summary theflyonthewall.com
10:04AM  Cardiome Pharma downgraded by RBC Capital Mkts Briefing.com
06:37AM  Cardiome downgraded to Market Perform from Outperform at Leerink theflyonthewall.com
19-Mar-12 09:18PM  Cardiome Investors: Why Shares Crashed 50% at Motley Fool -54.40%
06:15PM  Nasdaq stocks posting largest volume increases AP
05:43PM  Healthcare Business Recap: Merck Ceases Cardiome Pharma Development, St. Jude Medical Settles Dispute Wall St. Cheat Sheet
05:43PM  Healthcare Business Recap: Merck Ceases Cardiome Pharma Development, St. Jude Medical Settles Dispute at Wall St. Cheat Sheet
05:43PM  Healthcare Business Recap: Merck Ceases Cardiome Pharma Development, St. Jude Medical Settles Dispute
04:13PM  Most active Nasdaq-traded stocks AP
03:49PM  Cardiome Pharma shares sink as Merck drops project AP
Cardiome Pharma Corp., a biopharmaceutical company, engages in the discovery, development, and commercialization of therapies that enhance the health of patients. It offers BRINAVESS (vernakalant IV) for conversion of recent onset atrial fibrillation to sinus rhythm in adults; and develops vernakalant (oral) for atrial fibrillation. The company's pre-clinical research and development focuses on modulating cellular proteins (ion channels) that gate the movement of ions across the cell membrane to control various functions, including contraction of muscles, secretion from glands, and responses to foreign bodies and inflammation. It has operations in Canada, the United States, Switzerland, and the United Kingdom. The company was formerly known as Nortran Pharmaceuticals Inc. and changed its name to Cardiome Pharma Corp. in June 2001. Cardiome Pharma Corp. was founded in 1986 and is headquartered in Vancouver, Canada.